Document is current
Any future updates will be listed below
-
Authors
Klotsche, Jens https://orcid.org/0000-0002-2954-5755
Klein, Ariane
Niewerth, Martina
Hoff, Paula
Windschall, Daniel
Foeldvari, Ivan
Haas, Johannes-Peter
Horneff, Gerd
Minden, Kirsten
-
Funding
Funding for this research was provided by:
Deutsches Rheuma-Forschungszentrum Berlin (DRFZ)
- License Information
-
More Information
Article History
Received: 25 August 2020
Accepted: 29 March 2021
First Online: 16 April 2021
Declarations
:
: Written informed consent was obtained from both the parents and the patients (age ≥ 8 years) for participation in BiKeR, and again from the patients (age ≥ 18 years) for further follow-up in JuMBO. BiKeR was approved by the Ethics Committee of the Medical Council of North Rhine-Westphalia, Duesseldorf, Germany. JuMBO was approved by the Ethics Committee of Charité University Medicine Berlin. Both registers are conducted in accordance with the Declaration of Helsinki.
: Not applicable.
: JK: None declared; AK: None declared; MN: None declared; PH: None declared; DW: None declared; IF: Consultant of Novartis; JPH: None declared; GH Grant/research support from: Support from Abbvie, Chugai, Roche, Novartis, Pfizer, and MSD and speakers bureau Abbvie, Chugai, Roche, Novartis, Pfizer, MSD, and Bayer; KM: Consultant of GlaxoSmithKline and Sanofi and speakers bureau Roche.
